2 patents
Utility
Dosage forms of tissue kallikrein 1
2 Jan 24
Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 μg/kg to about 10.0 μg/kg, including subcutaneous and intravenous dosage forms.
Rick Pauls, Todd Verdoorn
Filed: 9 Mar 18
Utility
Ulinastatin polypeptides
15 Aug 23
Provided are ulinastatin glycoforms, ulinastatin fusion polypeptides, and related compositions, mixtures, and methods of use, including methods of recombinantly producing ulinastatin polypeptides and treating diseases.
Rick Pauls, Todd Verdoorn, Karl Frank Johnson, Gregory Thomas Bleck
Filed: 5 Mar 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first